Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 2 8Phase 3 4Phase 1 2Phase 2/3 1

Status

Active not recruiting 2Suspended 1Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Carcinoma, Non-Small-Cell Lung 147Breast Neoplasms 116Prostatic Neoplasms 61Multiple Myeloma 57Neoplasms 56Lung Neoplasms 50Neoplasm Metastasis 43Ovarian Neoplasms 36Parkinson Disease 4, Autosomal Dominant Lewy Body 35Colorectal Neoplasms 34Leukemia, Lymphocytic, Chronic, B-Cell 33Carcinoma, Renal Cell 27Recurrence 26Leukemia, Myeloid, Acute 26Urinary Bladder Neoplasms 25Carcinoma, Hepatocellular 24Small Cell Lung Carcinoma 23Myasthenia Gravis 22Triple Negative Breast Neoplasms 21Squamous Cell Carcinoma of Head and Neck 20Lymphoma, Large B-Cell, Diffuse 20Endometrial Neoplasms 20Melanoma 19Lymphoma, Follicular 19Nasopharyngeal Carcinoma 18Fallopian Tube Neoplasms 18Stomach Neoplasms 17Non-Muscle Invasive Bladder Neoplasms 16Brain Neoplasms 16Pancreatic Neoplasms 15

Interventions

pembrolizumab 1exemestane 1Watchful Waiting 1Tamoxifen 1Specimen Handling 1Radiotherapy 1Radiation 1Observation 1Metformin 1Magnetic Resonance Spectroscopy 1Letrozole 1Laser Therapy 1Anastrozole 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Breast Carcinoma In Situ × 90 days × Clear all
NCT02954874 2026-06-03

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
1,155 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended
1,156 enrolled
Breast

Breast Carcinoma In Situ

NCT05379153 2026-05-11

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
250 enrolled
Breast

Breast Carcinoma In Situ

NCT01905046 2026-04-28

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
86 enrolled 10 charts
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡